The role of the thymus in the pathogenesis of myasthenia gravis

Tohoku Journal of Experimental Medicine

Volumn 207, Issue 2, 2005, Pages 87-98

  Onodera, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; Myasthenia gravis; Thymus

Indexed keywords

AUTOANTIBODY; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; CHOLINESTERASE INHIBITOR; GLUCOCORTICOID; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; PLACEBO; CHEMOKINE; CHEMOKINE RECEPTOR;

ANTIBODY PRODUCTION; APOPTOSIS; B LYMPHOCYTE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; LYMPHOCYTE FUNCTION; MYASTHENIA GRAVIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMECTOMY; THYMOCYTE; THYMOMA; THYMUS FUNCTION; THYMUS HYPERPLASIA; TREATMENT OUTCOME; ANIMAL; AUTOIMMUNE DISEASE; BIOLOGICAL MODEL; IMMUNOLOGY; PATHOPHYSIOLOGY; THYMUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHEMOKINES; HUMANS; MODELS, BIOLOGICAL; MYASTHENIA GRAVIS; RECEPTORS, CHEMOKINE; THYMUS GLAND;

EID: 26944437493     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.207.87     Document Type: Review

References (27)

1. Balasa, B., Deng, C., Lee, J., Bradley, L.M., Dalton, D.K., Christadoss, P. & Sarvetnick, N. (1997) Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med., 186, 385-391.
2. Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., Carson, W.E. & Caligiuri, M.A. (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood, 97, 3146-3151.
3. Flores, K.G., Li, J., Sempowski, G.D., Haynes, B.F. & Hale, L.P. (1999) Analysis of the human thymic perivascular space during aging. J. Clin. Invest., 104, 1031-1039.
4. Forster, R., Mattis, A.E., Kremmer, E., Wolf, E., Brem, G. & Lipp, M. (1996) A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell, 87, 1037-1047.
5. Gronseth, G.S. & Barohn, R.J. (2000) Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 55, 7-15.
6. Gu, D., Wogensen, L., Calcutt, NA., Xia, C., Zhu, S., Merlie, J.P., Fox, H.S., Lindstrom, J., Powell, H.C. & Sarvetnick, N. (1995) Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction. J. Exp. Med., 181, 547-557.
7. Habu, S., Shimamura, K., Tamaoki, N., Kumagai, Y. & Okumura, K. (1986) Two natural killer cell populations which belong to T cell lineage in nude mice. Eur. J. Immunol., 16, 1453-1456.
8. Imai, T., Nagira, M., Takagi, S., Kakizaki, M., Nishimura, M., Wang, J., Gray, P.W., Matsushima, K. & Yoshie, O. (1999) Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol., 11, 81-88.
9. Kaminsky, S., Duquenoy, J.M. & Berrih-Aknin, S. (1993) Abnormal immunoregulation involving the IL-2/IL-2 receptor complex in myasthenia gravis. Ann. NY Acad. Sci., 681, 283-284.
10. Katchar, K., Eklund, A. & Grunewald, J. (2003) Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J. Intern. Med., 254, 564-571.
11. Kawaguchi, N., Kuwabara, S., Nemoto, Y., Fukutake, T., Satomura, Y., Arimura, K., Osame, M. & Hattori, T. (2004) The Study Group for Myasthenia Gravis in Japan. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. J. Neurol. Sci., 224, 43-47.
12. Kott, E., Hahn, T., Huberman, M., Levin, S. & Schattner, A. (1990) Interferon system and natural killer cell activity in myasthenia gravis. Q. J. Med., 76, 951-960.
13. Lindstrom, J.M., Seybold, M.E., Lennon, V.A., Whittingham, S. & Duane, D.D. (1976) Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology, 26, 1054-1059.
14. Moser, B., Schaerli, P. & Loetscher, P. (2002) CXCR5+ T cells: follicular homing takes center stage in T-helper-cell responses. Trends Immunol., 23, 250-254.
15. Nagata, T., Onodera, H., Ohuchi, M., Suzuki, Y., Tago, H., Fujihara, K., Ishii, N., Sugamura, K., Shoji, Y., Handa, M., Tabayashi, K. & Itoyama, Y. (2001) Decreased expression of c-myc family genes in thymuses from myasthenia gravis patients. J. Neuroimmunol., 115, 199-202.
16. Nakamura, Y., Russell, S.M., Mess, S.A., Friedmann, M., Erdos, M., Francois, C., Jacques, Y., Adelstein, S. & Leonard, W.J. (1994) Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature, 369, 330-333.
17. Ohuchi, M., Shimizu, M., Kawamoto, S., Shibuya, T., Ohmi, M., Onodera, H. & Itoyama, Y. (2001) Follow-up study of myasthenia gravis: evaluation of thymectomy in 300 patients. Brain and Nerve, 53, 723-727.
18. Onodera, H., Suzuki, Y., Tago, H. & Itoyama, Y. (2003) Chemokine receptor expression on T cells of patients with myasthenia gravis. Neurology, 60, A389.
19. Saito, R., Onodera, H., Tago, H., Suzuki, Y. & Itoyama, Y. (2005) Chemokine receptor CXCR5 expression on T cells in blood of myasthenia gravis before and after thymectomy. Neurology, 64, A79.
20. Sallusto, F., Lenig, D., Mackay, C.R. & Lanzavecchia, A. (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med., 187, 875-883.
21. Suzuki, N., Nakajima, A., Yoshino, S., Matsushima, K., Yagita, H. & Okumura, K. (1999) Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int. Immunol., 11, 553-559.
22. Suzuki, Y., Onodera, H., Tago, H., Saito, R., Ohuchi, M., Shimizu, M. & Itoyama, Y. (2005) Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis. J. Neuroimmunol., (in press).
23. Takeshita, T., Arita, T., Higuchi, M., Asao, H., Endo, K., Kuroda, H., Tanaka, N., Murata, K., Ishii, N. & Sugamura, K. (1997) STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity, 6, 449-457.
24. Vincent, A., Palace, J. & Hilton-Jones, D. (2001) Myasthenia gravis. Lancet, 357, 2122-2128.
25. Yi, Q., Ahlberg, R., Pirskanen, R. & Lefvert, A.K. (1994) Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J. Neuroimmunol., 50, 177-186.
26. Yoshie, O., Imai, T. & Nomiyama, H. (2001) Chemokines in immunity. Adv. Immunol., 78, 57-110.
27. Yoshimoto, T. & Paul, W.E. (1994) CD4pos NK1.1pos T cells promptly produced Il-4 in response to in vivo challenge with anti-CD3. J. Exp. Med., 179, 1285-1295.